Journey Medical Corp (DERM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product revenue, net | 15,009 | 13,139 | 14,629 | 14,855 |
| Cost of revenue | - | - | 5,285 | 6,541 |
| Research and development | - | 39 | 842 | 913 |
| Selling, general and administrative | 11,882 | 10,569 | 11,396 | 10,328 |
| Cost of goods sold - (excluding amortization of acquired intangible assets) | 4,939 | 4,790 | - | - |
| Amortization of acquired intangible assets | 1,064 | 1,065 | - | - |
| Total operating expenses | 17,885 | 16,463 | 17,523 | 17,782 |
| Loss from operations | -2,876 | -3,324 | -2,894 | -2,927 |
| Gain (loss) on extinguishment of debt | - | - | 1,125 | - |
| Interest expense | 937 | 891 | 758 | 563 |
| Foreign exchange transaction losses | -61 | -7 | -51 | -32 |
| Interest income | 138 | 149 | 188 | 161 |
| Total other expense (income) | -860 | -749 | 504 | -434 |
| Loss before income taxes | -3,736 | -4,073 | -2,390 | -3,361 |
| Income tax expense | 60 | - | - | - |
| Net loss | -3,796 | -4,073 | -2,390 | -3,361 |
| Earnings per share, basic | -0.16 | -0.18 | -0.12 | -0.17 |
| Earnings per share, diluted | -0.16 | -0.18 | -0.12 | -0.17 |
| Weighted average number of shares outstanding, basic | 23,290,806 | 22,611,040 | 20,537,794 | 19,993,858 |
| Weighted average number of shares outstanding, diluted | 23,290,806 | 22,611,040 | 20,537,794 | 19,993,858 |